Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists
- PMID: 2448008
- DOI: 10.1016/0169-328x(87)90041-6
Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists
Abstract
The effects of dopamine agonists and antagonists on rat basal ganglia substance P, substance K, and preprotachykinin mRNA were examined. Chronic administration of the prototypical dopamine antagonist haloperidol decreased striatal preprotachykinin mRNA and nigral tachykinin peptides. Chronic treatment with the dopamine D2 receptor antagonist L-sulpiride (but not the inactive D-isomer) mimicked the effect of haloperidol. In contrast, the atypical neuroleptic clozapine did not decrease tachykinin mRNA or peptides. The potent indirect dopamine agonist methamphetamine rapidly increased preprotachykinin mRNA, substance P, and substance K although the direct agonist apomorphine was without effect. Methamphetamine-stimulated changes in preprotachykinin mRNA were prevented by prior haloperidol administration. These data demonstrate that alterations in dopaminergic transmission significantly alter striatonigral tachykinin biosynthesis in vivo.
Similar articles
-
Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.Synapse. 1990;6(1):1-9. doi: 10.1002/syn.890060102. Synapse. 1990. PMID: 1697986
-
Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.J Pharmacol Exp Ther. 1987 Nov;243(2):792-8. J Pharmacol Exp Ther. 1987. PMID: 2445959
-
Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.J Biol Chem. 1986 May 25;261(15):6640-2. J Biol Chem. 1986. PMID: 2422168
-
Preprotachykinin gene expression in the forebrain: regulation by dopamine.Ann N Y Acad Sci. 1991;632:31-7. doi: 10.1111/j.1749-6632.1991.tb33091.x. Ann N Y Acad Sci. 1991. PMID: 1952630 Review. No abstract available.
-
Dopamine, serotonin and tachykinin in self-injurious behavior.Life Sci. 1996 May 24;58(26):2367-75. doi: 10.1016/0024-3205(96)00121-x. Life Sci. 1996. PMID: 8691981 Review.
Cited by
-
Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum.J Mol Neurosci. 1992;3(4):197-201. doi: 10.1007/BF03380139. J Mol Neurosci. 1992. PMID: 1390000
-
Dopamine receptor gene expression by enkephalin neurons in rat forebrain.Proc Natl Acad Sci U S A. 1990 Jan;87(1):230-4. doi: 10.1073/pnas.87.1.230. Proc Natl Acad Sci U S A. 1990. PMID: 2296581 Free PMC article.
-
Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.J Neuroinflammation. 2018 Feb 21;15(1):52. doi: 10.1186/s12974-018-1087-7. J Neuroinflammation. 2018. PMID: 29467000 Free PMC article.
-
Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.Brain Res. 2004 May 8;1007(1-2):124-31. doi: 10.1016/j.brainres.2004.01.077. Brain Res. 2004. PMID: 15064143 Free PMC article.
-
Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.Cell Mol Neurobiol. 1990 Mar;10(1):127-44. doi: 10.1007/BF00733640. Cell Mol Neurobiol. 1990. PMID: 1970756 Free PMC article.